Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation

Relevance. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) makes it possible to treat severe malignant and non-malignant hematopoietic disorders system. Pulmonary complications (PC) occur in 40–60 % of patients after allo-HSCT. However to date, the effect of HSCT on functional and mor...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Frolova, A. G. Volkova, O. V. Paina, P. V. Kozhokar, K. A. Ekushov, Zh. Z. Rakhmanova, L. A. Cvetkova, E. D. Dobrovolskaya, B. I. Smirnov, E. A. Kulagin, T. A. Bykova, E. V. Semenova, L. S. Zubarovskaya
Format: Article
Language:Russian
Published: Academician I.P. Pavlov First St. Petersburg State Medical University 2022-11-01
Series:Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:
Online Access:https://www.sci-notes.ru/jour/article/view/909
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241321350365184
author A. S. Frolova
A. G. Volkova
O. V. Paina
P. V. Kozhokar
K. A. Ekushov
Zh. Z. Rakhmanova
L. A. Cvetkova
E. D. Dobrovolskaya
B. I. Smirnov
E. A. Kulagin
T. A. Bykova
E. V. Semenova
L. S. Zubarovskaya
author_facet A. S. Frolova
A. G. Volkova
O. V. Paina
P. V. Kozhokar
K. A. Ekushov
Zh. Z. Rakhmanova
L. A. Cvetkova
E. D. Dobrovolskaya
B. I. Smirnov
E. A. Kulagin
T. A. Bykova
E. V. Semenova
L. S. Zubarovskaya
author_sort A. S. Frolova
collection DOAJ
description Relevance. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) makes it possible to treat severe malignant and non-malignant hematopoietic disorders system. Pulmonary complications (PC) occur in 40–60 % of patients after allo-HSCT. However to date, the effect of HSCT on functional and morphological pulmonary changes in recipients remains insufficiently studied.The objective of current study was to evaluate risk factors affecting long-term survival in children and adolescents after allo-HSCT.Methods and materials. The current study was both retrospective and prospective. The analysis included 362 patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), aged 5 months to 18 years, who received allo-HSCT at Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation in 2000–2018. All the patients underwent chest computed tomography (CT). When detecting CT changes, we performed fibrobronchoscopy (FBS) with microbiological examination of bronchoalveolar lavage (BAL).Results. PC were diagnosed in 124 patients (64 %) who received allo-HSCT in 2014–2018. Decrease of overall survival (OS) is associated with PC development during the first year after allo-HSCT(р<0,001).The development of early PC in remission of the underlying disease significantly affected OS (p=0.001).The probability of PC development is 2.26 times higher in patients older than 9 years (p=0.006). When comparing the intensity of conditioning regimens (MACvsRIC) in remission of the underlying disease, we did not get significant differences in the incidence of PC (p>0.05). Graft source, donor type, HLA-compatibility, recipient gender did not affect the incidence of PC (p>0.05). When using graft-versus-host disease (GVHD) prophylaxis (ptCYvsATG), the 5-year OS in patients without PC was 78.8 % and 62.8 %respectively. The 5-year OS in patients with PC was 51.8 % and 42.4 % respectively (р=0.007). Decrease of OS in patients with PC is associated with chGVHD(58.3 %,) (р=0.03).Conclusion. Pulmonary complications (infectious and non-infectious) in allo-HSCT recipients are more likely to occur in the first year after transplantation. Among bacterial pathogens, the predominance of Gr(-) flora remains. The incidence of pulmonary complications was significantly lower when using ptCY as a prevention of GVHD.
format Article
id doaj-art-4798da693be74e02beec0aebcaf1a834
institution Kabale University
issn 1607-4181
2541-8807
language Russian
publishDate 2022-11-01
publisher Academician I.P. Pavlov First St. Petersburg State Medical University
record_format Article
series Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
spelling doaj-art-4798da693be74e02beec0aebcaf1a8342025-08-20T04:00:13ZrusAcademician I.P. Pavlov First St. Petersburg State Medical UniversityУчёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова1607-41812541-88072022-11-01293819010.24884/1607-4181-2022-29-3-81-90603Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantationA. S. Frolova0A. G. Volkova1O. V. Paina2P. V. Kozhokar3K. A. Ekushov4Zh. Z. Rakhmanova5L. A. Cvetkova6E. D. Dobrovolskaya7B. I. Smirnov8E. A. Kulagin9T. A. Bykova10E. V. Semenova11L. S. Zubarovskaya12Pavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversitySaint Petersburg Electrotechnical University “LETI”Pavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversityRelevance. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) makes it possible to treat severe malignant and non-malignant hematopoietic disorders system. Pulmonary complications (PC) occur in 40–60 % of patients after allo-HSCT. However to date, the effect of HSCT on functional and morphological pulmonary changes in recipients remains insufficiently studied.The objective of current study was to evaluate risk factors affecting long-term survival in children and adolescents after allo-HSCT.Methods and materials. The current study was both retrospective and prospective. The analysis included 362 patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), aged 5 months to 18 years, who received allo-HSCT at Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation in 2000–2018. All the patients underwent chest computed tomography (CT). When detecting CT changes, we performed fibrobronchoscopy (FBS) with microbiological examination of bronchoalveolar lavage (BAL).Results. PC were diagnosed in 124 patients (64 %) who received allo-HSCT in 2014–2018. Decrease of overall survival (OS) is associated with PC development during the first year after allo-HSCT(р<0,001).The development of early PC in remission of the underlying disease significantly affected OS (p=0.001).The probability of PC development is 2.26 times higher in patients older than 9 years (p=0.006). When comparing the intensity of conditioning regimens (MACvsRIC) in remission of the underlying disease, we did not get significant differences in the incidence of PC (p>0.05). Graft source, donor type, HLA-compatibility, recipient gender did not affect the incidence of PC (p>0.05). When using graft-versus-host disease (GVHD) prophylaxis (ptCYvsATG), the 5-year OS in patients without PC was 78.8 % and 62.8 %respectively. The 5-year OS in patients with PC was 51.8 % and 42.4 % respectively (р=0.007). Decrease of OS in patients with PC is associated with chGVHD(58.3 %,) (р=0.03).Conclusion. Pulmonary complications (infectious and non-infectious) in allo-HSCT recipients are more likely to occur in the first year after transplantation. Among bacterial pathogens, the predominance of Gr(-) flora remains. The incidence of pulmonary complications was significantly lower when using ptCY as a prevention of GVHD.https://www.sci-notes.ru/jour/article/view/909lung complicationsallogeneic hematopoietic stem cell transplantationacute leukemiachildren
spellingShingle A. S. Frolova
A. G. Volkova
O. V. Paina
P. V. Kozhokar
K. A. Ekushov
Zh. Z. Rakhmanova
L. A. Cvetkova
E. D. Dobrovolskaya
B. I. Smirnov
E. A. Kulagin
T. A. Bykova
E. V. Semenova
L. S. Zubarovskaya
Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
lung complications
allogeneic hematopoietic stem cell transplantation
acute leukemia
children
title Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
title_full Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
title_fullStr Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
title_full_unstemmed Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
title_short Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
title_sort pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
topic lung complications
allogeneic hematopoietic stem cell transplantation
acute leukemia
children
url https://www.sci-notes.ru/jour/article/view/909
work_keys_str_mv AT asfrolova pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT agvolkova pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT ovpaina pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT pvkozhokar pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT kaekushov pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT zhzrakhmanova pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT lacvetkova pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT eddobrovolskaya pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT bismirnov pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT eakulagin pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT tabykova pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT evsemenova pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation
AT lszubarovskaya pulmonarycomplicationsinchildrenandadolescentsafterallogeneichematopoieticstemcelltransplantation